Nucleoside phosphoramidates

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8716262
APP PUB NO 20110015146A1
SERIAL NO

12645765

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A nucleoside compound having activity against hepatitis C virus is disclosed.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • GILEAD PHARMASSET LLC

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Du, Jinfa New Hope, US 60 1915
Nagarathnam, Dhanapalan Bethany, US 87 2015
Sofia, Michael Joseph Doylestown, US 38 2378
Wang, Peiyuan Glen Rock, US 76 2043

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Nov 6, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00